Related News
Charity program launched to enhance prevention and control of cardiovascular diseases
Online Edition
There are 290 million people with cardiovascular diseases in China now and cardiovascular disease has become the cause of over 40 percent of deaths in the nation, experts told the Oriental Congress of Cardiology over the weekend.
To enhance disease prevention and control, China Cardiovascular Health Association, a charity platform of cardiovascular disease in China, signed agreement with world-leading pharmaceutical company Pfizer during the congress to help build grassroots chronic disease management and chest pain centers to extend disease prevention and treatment network to county-based health authorities.
Professional trainings for medical staff and cardiovascular health management based big data are also included into the program.
“Our purpose is to have 90 percent of cardiovascular patients treated in their hometown through perfecting hypertension management and improving county-level hospitals’ ability on acute chest pain treatment to drop casualty and improve treatment effects,” said Dr Huo Yong, vice president of China Cardiovascular Health Association.
Collection for the nation’s first cardiology museum also kicked off during the congress, as patients and doctors, who have documents and items to show the development of Chinese history on cardiology treatment, are encouraged to donate for the museum, which will start construction soon.
China’s cardiology started in 1950s and 60 and has bloomed since 1980s.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
